Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 33% ± 9% |
Insufficient scRNA-seq data for expression of AGBL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 99% | 297.08 | 88 / 89 | 64% | 1.94 | 575 / 901 |
ovary | 99% | 266.87 | 179 / 180 | 62% | 1.60 | 265 / 430 |
pancreas | 94% | 92.81 | 308 / 328 | 52% | 0.88 | 93 / 178 |
liver | 97% | 475.15 | 220 / 226 | 45% | 1.25 | 181 / 406 |
lung | 93% | 482.00 | 536 / 578 | 49% | 1.21 | 561 / 1155 |
thymus | 100% | 299.16 | 652 / 653 | 41% | 0.79 | 246 / 605 |
uterus | 95% | 248.32 | 162 / 170 | 35% | 0.77 | 162 / 459 |
esophagus | 79% | 56.95 | 1136 / 1445 | 51% | 1.04 | 93 / 183 |
stomach | 90% | 85.95 | 324 / 359 | 35% | 0.61 | 99 / 286 |
breast | 73% | 93.11 | 336 / 459 | 50% | 1.08 | 560 / 1118 |
bladder | 86% | 178.52 | 18 / 21 | 37% | 0.76 | 187 / 504 |
intestine | 93% | 164.61 | 896 / 966 | 26% | 0.46 | 138 / 527 |
prostate | 99% | 274.49 | 243 / 245 | 19% | 0.29 | 94 / 502 |
skin | 82% | 68.75 | 1477 / 1809 | 24% | 0.41 | 115 / 472 |
adrenal gland | 96% | 268.25 | 247 / 258 | 7% | 0.12 | 17 / 230 |
spleen | 100% | 216.46 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.18 | 1 / 1 |
brain | 66% | 140.32 | 1738 / 2642 | 25% | 0.58 | 175 / 705 |
lymph node | 0% | 0 | 0 / 0 | 62% | 1.16 | 18 / 29 |
adipose | 56% | 38.45 | 678 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 53% | 77.77 | 488 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 50% | 29.33 | 674 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 0.41 | 12 / 45 |
eye | 0% | 0 | 0 / 0 | 25% | 0.40 | 20 / 80 |
heart | 20% | 10.39 | 172 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.65 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0035610 | Biological process | protein side chain deglutamylation |
GO_0005814 | Cellular component | centriole |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | AGBL2 |
Protein name | Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) AGBL carboxypeptidase 2 Cytosolic carboxypeptidase 2 (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) |
Synonyms | hCG_2042982 CCP2 |
Description | FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of tubulin and non-tubulin target proteins. Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of tubulin protein. Specifically cleaves tubulin long-side-chains, while it is not able to remove the branching point glutamate. Also catalyzes the removal of polyglutamate residues from the carboxy-terminus of non-tubulin proteins such as MYLK. . |
Accessions | Q5U5Z8 ENST00000530577.5 ENST00000645431.2 [Q5U5Z8-1] ENST00000532595.5 ENST00000525123.6 [Q5U5Z8-1] ENST00000530969.1 J9JIH1 ENST00000528244.5 E9PS54 F6U0I4 ENST00000529154.5 ENST00000528609.5 E9PJH3 A0A140VKH9 E9PR59 E9PRJ1 E9PI49 ENST00000528632.5 |